SAINT™ delivery technology is based on a set of proprietary, entirely synthetic, cationic lipid structures which have demonstrated to be safe and non-toxic both in vitro and in vivo. Due to its cationic headgroup and amphiphilic nature, SAINT lipids readily bind to most biomolecules and to cellular membranes, facilitating efficient uptake and release of these biomolecules inside cells. Synvolux established an expanding, proprietary OptiSAINT™ library of more than 90 different SAINT formulations, from which the best performing candidates are selected for various applications and different cell lines. SAINT-based formulations and its applications are covered by more than 20 issued patents and patent applications.

SAINT lipids have been shown to be very effective in transporting DNA, RNA (siRNA and mRNA) and proteins to the target destination, both in vitro and in vivo. In head-to-head comparisons by us and many of our customers, SAINT lipids have demonstrated to reach similar or much higher transfection efficiencies (depending on the cell type) than competing, well-known products from large companies that charge about 3 times as much for their products. In addition, SAINT lipids are extremely stable over long periods of time, are very mild to cells, and offer specific advantages for GMP production.